SAFEs Explained: What They Are, How They Work, and When to Use One

Here is how decisively the argument has been settled in the United States. In the first quarter of 2026, SAFEs accounted for 93% of pre-seed rounds, while convertible notes fell to a record low of just 7%, according to Carta’s State of Pre-Seed data. For US founders raising before a priced round, the instrument question is, for most, no longer a real debate.

But two things separate a founder who signs the right SAFE from one who discovers the consequences two years later at a priced round: understanding exactly how the “future equity” part works, and knowing that outside the US, in Africa in particular, the picture looks very different. This post covers both. It pairs with our guide to convertible notes, and if you want to know which to use, read SAFE vs convertible note vs priced round.

What a SAFE actually is

A SAFE, or Simple Agreement for Future Equity, was created by the accelerator Y Combinator in 2013 to make early fundraising fast and cheap. In plain terms, it is a promise: an investor gives you money today, and in return you promise to give them shares in the future, when you next raise a priced round.

The key word is future. A SAFE does not make the investor a shareholder today, and it does not set a price for your company today. It simply says: when you do a proper priced round, this money converts into shares, on terms we agree now. Because there is no valuation to negotiate and very little to draft, a SAFE can be signed in days, which is exactly why pre-seed rounds lean on it so heavily.

Crucially, a SAFE is not debt. There is no interest, no repayment date, and no obligation to pay anything back in cash. Because it is not debt, it also does not sit on your balance sheet as a liability, which keeps your accounts cleaner during diligence. Both of these are the main ways it differs from a convertible note, which is a loan that converts and does appear as a liability until it does.

The terms that decide everything

A SAFE converts into shares later, but on what terms? Two levers do almost all the work, and they exist to reward the investor for taking the early risk.

The valuation cap. This is the maximum company valuation at which the investor’s money converts. Suppose an investor puts money in on a SAFE with a 5 million dollar cap. If your next priced round values the company at 10 million, the SAFE investor does not convert at 10 million. They convert as if the company were worth 5 million, which means their money buys twice as many shares. The cap protects early investors from being penalised for backing you before you were valuable. In practice, US pre-seed caps commonly sit in the 6 to 15 million dollar range.

The discount. Instead of, or sometimes alongside, a cap, a SAFE may carry a discount: the investor converts at a percentage below the price new investors pay, typically around 20%. A 20% discount means if new money comes in at a 1.00 share price, the SAFE converts at 0.80, buying more shares for the same money.

Increasingly, though, US SAFEs skip the discount entirely and use a cap only, which has become the dominant structure precisely because it is simpler and cleaner on the cap table. There is also sometimes a most-favoured-nation (MFN) clause, which lets an early investor claim the best terms you later give any other SAFE investor. Watch this one: if you issue a first SAFE with an MFN and later issue a cheaper one, the first investor can upgrade, and founders often forget until they are mid-close on the second.

Pre-money versus post-money: the detail most founders miss

This is the distinction that creates the most expensive surprises, so it is worth slowing down. Modern SAFEs are post-money SAFEs. Across 2021 to 2025, post-money SAFEs grew from just over 60% to nearly 90% of all SAFEs, per Carta. Pre-money SAFEs are effectively legacy instruments now; if someone hands you one, ask why.

The word “post-money” changes who bears the dilution. A post-money SAFE fixes the investor’s ownership percentage after all the SAFE money has converted. A 500,000 dollar cheque on a 5 million post-money cap gives the investor exactly 10% (500,000 divided by 5,000,000), and that percentage is fixed and predictable no matter how many other SAFEs stack on top. That certainty is why investors like it. But it has a consequence founders miss: every additional SAFE you sign dilutes you, the founder, not the earlier SAFE investors. Their percentages are locked; yours absorbs each new one.

An older pre-money SAFE calculated ownership before conversion, so multiple SAFEs diluted each other and the founder’s dilution was more spread out. Post-money is cleaner for investors, which is why it won, but it quietly shifts more of the dilution onto the founder. The lesson is not to avoid post-money SAFEs; it is to know that they stack on you, and to add up their total effect before you sign the next one.

A worked example

Say you raise 500,000 dollars on post-money SAFEs with a 5 million dollar cap. A year later you raise a priced seed round at a 10 million dollar valuation.

• Because the priced round (10 million) is above the cap (5 million), the SAFE converts at the 5 million cap.
• Converting 500,000 dollars at a 5 million post-money cap gives the SAFE investors 10% of the company.
• The new seed investors, coming in at 10 million, pay full price for their stake.

Because you grew in value between the SAFE and the round, the early investors’ 500,000 bought them a 10% stake that would have cost a million at the new price. That is the cap doing its job, rewarding them, and diluting you, for the early risk. Sign several capped SAFEs and each converts this way; the combined bite is almost always larger than founders expect when they look at each SAFE in isolation.

The founder’s discipline

SAFEs are genuinely founder-friendly: fast, cheap, and they avoid a premature valuation fight. But their ease is also their trap. Because each one feels small and no cap table changes at signing, founders sign several and only feel the combined dilution when they all convert at once in the priced round.

The discipline is non-negotiable: before you sign any SAFE, model what all your outstanding SAFEs will convert into at a realistic next-round valuation, and keep a running total of the ownership you have already promised away. This is exactly the kind of pro forma cap table work that experienced corporate finance practitioners do before any transaction, and it is the difference between negotiating your seed round with clear eyes and negotiating it blind. If you also know the three numbers investors check, you can sense-check whether the cap you are agreeing reflects real progress or just optimism.

SAFEs in the African context

Here is where the US consensus stops travelling. In Africa, the SAFE is far from universal, for two structural reasons. First, debt is a much larger part of the market: in 2025, debt financing reached a record 1.64 billion dollars, or 41% of all African tech capital, according to Partech’s 2025 Africa Tech VC Report. A market that funds itself so heavily with debt is one where convertible notes and other structures remain very much alive, and where a local investor may be more comfortable with a note than a SAFE.

Second, currency. Because most African rounds are struck in US dollars while founders earn in local currency, a dollar-denominated SAFE means you are promising away dollar value that grows in local terms if the currency weakens, which ties your cap table directly to the currency discipline we cover separately. Whichever instrument you use, get it adapted to your actual jurisdiction of incorporation rather than lifted from a US template; a SAFE written for a Delaware entity does not automatically work for a company registered in Lagos or Nairobi.

Common SAFE mistakes

• Signing serial SAFEs without a running total. The dilution is invisible until conversion. Track it from the first one.
• Agreeing a cap that is too low. A low cap feels cheap to close, but it hands away a large chunk of the company at the priced round. The cap is the negotiation.
• Ignoring the post-money stacking effect. Every new post-money SAFE dilutes you, not the earlier investors.
• Forgetting an MFN clause you granted. It lets an early investor upgrade to any better terms you give later.
• Using a US template in the wrong jurisdiction. Adapt it to where you are actually incorporated.

Used well, a SAFE is the fastest, cleanest way to take early money without a valuation fight, which is why it has swept the US market. Used carelessly, or imported unadapted into an African deal, it is a promise you do not fully feel until the priced round arrives. To see how it compares with the alternatives, read SAFE vs convertible note vs priced round, and for the full journey, start with the complete guide to startup funding.